CHILTON CAPITAL MANAGEMENT LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1056859 HOUSTON, TX

Position in VRTX

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$12,914

-$12,985 QoQ

Shares Held

-55.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,585

of 1,705 holders

Holding Since

Dec 2021

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHILTON CAPITAL MANAGEMENT LLC holds $30,082 across 6 Biotechnology names. VRTX ranks #1 (42.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	26	$12,914
2	CVM	Cel Sci Corp	9,156	$9,522
3	ALNY	Alnylam Pharmaceuticals, Inc.	13	$3,913
4	AGEN	Agenus Inc	1,058	$3,237
5	CRBP	Corbus Pharmaceuticals Holdings, Inc.	29	$272
6	ARVN	Arvinas, Inc.	27	$224

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,914	26	-55.2%	Shares	Sole	2026-08-04
2026-03-31	$25,899	58	+5700.0%	Shares	Sole	2026-05-11
2025-12-31	$453	1	-92.3%	Shares	Sole	2026-02-12
2024-12-31	$5,235	13	-85.4%	Shares	Sole	2025-02-07
2021-12-31	$19,544	89	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.